Westfield Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-8,495
Closed -$1.96M 281
2016
Q2
$1.96M Sell
8,495
-874
-9% -$202K 0.02% 233
2016
Q1
$2.51M Sell
9,369
-4,191
-31% -$1.2M 0.02% 221
2015
Q4
$4.24M Sell
13,560
-5,770
-30% -$1.72M 0.03% 225
2015
Q3
$5.25M Sell
19,330
-822,042
-98% -$253M 0.04% 206
2015
Q2
$255M Sell
841,372
-196,810
-19% -$58.7M 1.56% 7
2015
Q1
$309M Sell
1,038,182
-21,613
-2% -$6.16M 1.78% 6
2014
Q4
$273M Buy
1,059,795
+7,265
+0.7% +$1.82M 1.61% 6
2014
Q3
$254M Sell
1,052,530
-401,432
-28% -$89.8M 1.55% 5
2014
Q2
$324M Sell
1,453,962
-41,428
-3% -$8.58M 1.93% 4
2014
Q1
$308M Sell
1,495,390
-100,115
-6% -$19.8M 1.84% 3
2013
Q4
$268M Buy
1,595,505
+214,643
+16% +$33.6M 1.58% 4
2013
Q3
$199M Sell
1,380,862
-25,608
-2% -$3.41M 1.27% 7
2013
Q2
$178M Buy
+1,406,470
New +$159M 1.22% 8

Other funds holding AGN

Westfield Capital Management's AGN Position: Q3 2016 in Review

Westfield Capital Management sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 8,495 shares — an estimated $1.96M sold.

Westfield Capital Management first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $324M in Q2 2014. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Westfield Capital Management reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Westfield Capital Management sold 8,495 Allergan plc shares in Q3 2016, an estimated $1.96M.
  • Westfield Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Westfield Capital Management's Allergan plc position peaked at $324M in Q2 2014.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Westfield Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.